Similarly, the higher incidence of neutropenia observed with palbociclib is consistent with previously reported clinical data [37, 38] although only neutropenia events requiring prescription of G-CSF drugs were captured herein, per the definition of neutropenia used in this study. This evidence concerns the gene CSF3 and Decreased total neutrophil count.